Literature DB >> 6895884

Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China.

Y Zeng, L G Zhang, H Y Li, M G Jan, Q Zhang, Y C Wu, Y S Wang, G R Su.   

Abstract

A serological mass survey was carried out in Wuzhou City of the Guangxi Autonomous Region, China. Sera were collected from 12,932 persons between the ages of 40 and 59. The positive rate of VCA/IgA antibody-positive person was 5.3%, but no EA/IgA antibody was found in sera from VCA/Iga-negative persons. Thirteen and nine nasopharyngeal carcinoma (NPC) patients were detected from the VCA/Iga and EA/IgA antibody-positive persons, respectively. With the present combination method the detection rate of NPC for 12,932 persons was 100.5/100,000 and for 680 VCA/IgA antibody-positive persons it was 1,900/100,000. Thus, the rate was twice and 37 times higher, respectively, than the annual incidence rate of NPC in persons of the same age group from 1975-1978 in Wuzhou City. Of 13 NPC patients, 9 were in stage I (70%) and 4 in stage II (30%). Therefore, it is possible to reduce the mortality rate of NPC in Wuzhou City by radiotherapy of NPC patients in the early stage of the disease. The present results further suggest that EB virus is closely associated with NPC.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6895884     DOI: 10.1002/ijc.2910290204

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.

Authors:  Anna E Coghill; Wan-Lun Hsu; Ruth M Pfeiffer; Hedy Juwana; Kelly J Yu; Pei-Jen Lou; Cheng-Ping Wang; Jen-Yang Chen; Chien-Jen Chen; Jaap M Middeldorp; Allan Hildesheim
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-27       Impact factor: 4.254

2.  An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models.

Authors:  Cheuk Wai Choi; Michael C H Lee; Wai Tong Ng; Lai Yau Law; Tsz Kok Yau; Anne W M Lee
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

Review 3.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

4.  Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.

Authors:  Liangru Ke; Hufeng Zhou; Chong Wang; Geng Xiong; Yanqun Xiang; Yihong Ling; Abdelmajid Khabir; George S Tsao; Yixin Zeng; Musheng Zeng; Pierre Busson; Elliott Kieff; Xiang Guo; Bo Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-22       Impact factor: 11.205

5.  Antibody responses to recombinant Epstein-Barr virus antigens in nasopharyngeal carcinoma patients: complementary test of ZEBRA protein and early antigens p54 and p138.

Authors:  R Dardari; W Hinderer; D Lang; A Benider; B El Gueddari; I Joab; A Benslimane; M Khyatti
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.

Authors:  J Fachiroh; D K Paramita; B Hariwiyanto; A Harijadi; H L Dahlia; S R Indrasari; H Kusumo; Y S Zeng; T Schouten; S Mubarika; J M Middeldorp
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China.

Authors:  Xiuchan Guo; Randall C Johnson; Hong Deng; Jian Liao; Li Guan; George W Nelson; Mingzhong Tang; Yuming Zheng; Guy de The; Stephen J O'Brien; Cheryl A Winkler; Yi Zeng
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

8.  Outcomes of nasopharyngeal carcinoma screening for high risk family members in Hong Kong.

Authors:  Wai Tong Ng; Cheuk Wai Choi; Michael C H Lee; Lai Yau Law; Tsz Kok Yau; Anne W M Lee
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

Review 9.  Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature.

Authors:  Anna E Coghill; Allan Hildesheim
Journal:  Am J Epidemiol       Date:  2014-08-28       Impact factor: 4.897

10.  Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population.

Authors:  M Tang; Y Zeng; A Poisson; D Marti; L Guan; Y Zheng; H Deng; J Liao; X Guo; S Sun; G Nelson; G de Thé; C A Winkler; S J O'Brien; M Carrington; X Gao
Journal:  Genes Immun       Date:  2010-01-14       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.